Breaking News, Promotions & Moves

Pfizer Names New Chief Scientific Officer and President of R&D

Dr. Chris Boshoff will oversee all functions of Research & Development across all therapeutic areas.

Author Image

By: Charlie Sternberg

Associate Editor

After a comprehensive internal and external selection process, Pfizer Inc. has appointed Chris Boshoff, M.D., PhD, as Chief Scientific Officer and President, Research & Development effective January 1, 2025.   Dr. Boshoff, who most recently served as Chief Oncology Officer and Executive Vice President, will succeed Dr. Mikael Dolsten. In his new role, Boshoff will remain a member of Pfizer’s Executive Leadership Team, reporting to Chairman and Chief Executive Officer, Dr. Albert Bourla, an...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters